Clinical Outcomes of Soft Tissue Sarcoma around the Elbow Joint: A Retrospective Single Institution Study.

Q2 Medicine

Sarcoma Pub Date : 2022-01-01 DOI:10.1155/2022/1087726

Edelyn S Azurin, Norio Yamamoto, Katsuhiro Hayashi, Akihiko Takeuchi, Kaoru Tada, Shinji Miwa, Kentaro Igarashi, Takashi Higuchi, Hirotaka Yonezawa, Sei Morinaga, Yohei Asano, Shiro Saito, Hiroyuki Tsuchiya

{"title":"Clinical Outcomes of Soft Tissue Sarcoma around the Elbow Joint: A Retrospective Single Institution Study.","authors":"Edelyn S Azurin, Norio Yamamoto, Katsuhiro Hayashi, Akihiko Takeuchi, Kaoru Tada, Shinji Miwa, Kentaro Igarashi, Takashi Higuchi, Hirotaka Yonezawa, Sei Morinaga, Yohei Asano, Shiro Saito, Hiroyuki Tsuchiya","doi":"10.1155/2022/1087726","DOIUrl":null,"url":null,"abstract":"Background: We report a retrospective case series analysis of clinical outcomes of patients with soft tissue sarcoma around the elbow.Methods: Twenty-two patients underwent surgical tumor excision between January 1999 and May 2017, with a mean follow-up of 85.2 months.Results: Six tumors were localized in the upper arm, nine in the elbow, and seven in the forearm. Sixteen tumors were deep-seated, and six were superficially located. Fifteen patients underwent wide excision, including one amputation, and 18 achieved (81.8%) negative margins histologically. Two local recurrences and four distant metastases developed. The mean Musculoskeletal Tumor Society score was 92.0% (range, 33.3-100). The 5-year local recurrence-free survival rate, metastasis-free survival rate, and overall survival rate were 90.0%, 77.0%, and 79.7%, respectively.Conclusions: Local control and limb function can have favorable outcomes when the tumor excised has a histologically negative margin without sacrificing the major structure.","PeriodicalId":21431,"journal":{"name":"Sarcoma","volume":"2022 ","pages":"1087726"},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9789912/pdf/","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Sarcoma","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2022/1087726","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 1

Abstract

Background: We report a retrospective case series analysis of clinical outcomes of patients with soft tissue sarcoma around the elbow.

Methods: Twenty-two patients underwent surgical tumor excision between January 1999 and May 2017, with a mean follow-up of 85.2 months.

Results: Six tumors were localized in the upper arm, nine in the elbow, and seven in the forearm. Sixteen tumors were deep-seated, and six were superficially located. Fifteen patients underwent wide excision, including one amputation, and 18 achieved (81.8%) negative margins histologically. Two local recurrences and four distant metastases developed. The mean Musculoskeletal Tumor Society score was 92.0% (range, 33.3-100). The 5-year local recurrence-free survival rate, metastasis-free survival rate, and overall survival rate were 90.0%, 77.0%, and 79.7%, respectively.

Conclusions: Local control and limb function can have favorable outcomes when the tumor excised has a histologically negative margin without sacrificing the major structure.

Abstract Image

查看原文本刊更多论文

肘关节周围软组织肉瘤的临床结果:一项回顾性单机构研究。

背景:我们报告了肘部周围软组织肉瘤患者临床结果的回顾性病例系列分析。方法:1999年1月至2017年5月，22例患者接受手术切除肿瘤，平均随访85.2个月。结果:上臂6例，肘部9例，前臂7例。16个肿瘤位于深部，6个位于浅表。15例患者接受了广泛切除，包括一例截肢，18例(81.8%)在组织学上达到阴性边缘。2例局部复发，4例远处转移。肌肉骨骼肿瘤学会平均评分为92.0%(范围33.3-100)。5年局部无复发生存率为90.0%，无转移生存率为77.0%，总生存率为79.7%。结论:在不牺牲主要结构的情况下，切除组织学阴性边缘的肿瘤可获得良好的局部控制和肢体功能。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Sarcoma Medicine-Radiology, Nuclear Medicine and Imaging

CiteScore

5.00

自引率

0.00%

发文量

审稿时长

14 weeks

期刊介绍： Sarcoma is dedicated to publishing papers covering all aspects of connective tissue oncology research. It brings together work from scientists and clinicians carrying out a broad range of research in this field, including the basic sciences, molecular biology and pathology and the clinical sciences of epidemiology, surgery, radiotherapy and chemotherapy. High-quality papers concerning the entire range of bone and soft tissue sarcomas in both adults and children, including Kaposi"s sarcoma, are published as well as preclinical and animal studies. This journal provides a central forum for the description of advances in diagnosis, assessment and treatment of this rarely seen, but often mismanaged, group of patients.